Exelixis
EXEL
#1821
Rank
C$15.06 B
Marketcap
C$56.20
Share price
-0.49%
Change (1 day)
5.19%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company